ACUR - Acura Pharmaceuticals Stock Trading

PALATINE, Ill., March 30, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes associated with product misuse, anno...

PALATINE, Ill., March 23, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), today announced that Abuse Deterrent Pharma, LLC, its licensee of LTX-03 (Hydrocodone Bitartrate and Acetaminophen with Acura’s LIMITx™ Technology), has engaged Catalent Pharma Soluti...

Acura Pharmaceuticals ( OTCPK:ACUR ): Q3 GAAP EPS of $0.00. Revenue of $1.32M Press Release More news on: Acura Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,